Shai Novik
Vermögen: 51 725 $ am 31.10.2026
Vermögen: 51 725 $ am 31.10.2026
Mr. Shai A. Novik is an Executive Chairman at Enlivex Ltd. and a Chairman at Stentomics, Inc. He is on the Board of Directors at InnoVision Labs, Inc. and Odysseus Ventures Ltd. Mr. Novik was previously employed as a Chairman by Enlivex Therapeutics Ltd. /Old/, a Chairman by Autovative Products, Inc., a Chairman by InnoVision Labs, Inc., a President by OPKO Biologics Ltd., a Managing Director by A-Online Capital (A.O.C.) Ltd., a Chief Operating Officer & Head-Strategic Planning by THCG, Inc., a Chief Operating Officer by Invmetrics Holdings, Inc., and a Chairman by Sharp Vision, Inc. He also served on the board at Cazador Acquisition Corp.
Ltd. and Ucansi, Inc. He received his MBA from Cornell University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENLIVEX LTD. 1,9 % | 18.03.2026 | 29 059 ( 1,9 % ) | 51 725 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ENLIVEX LTD. | Vorsitzender | 01.01.2014 |
| INNOVISION LABS, INC. | Direktor/Vorstandsmitglied | 01.01.2013 |
Stentomics, Inc. | Gründer | 06.09.2010 |
Odysseus Ventures Ltd. | Direktor/Vorstandsmitglied | 06.09.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Gründer | 01.01.2014 |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Vorsitzender | 12.08.2013 |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Direktor/Vorstandsmitglied | 12.08.2013 |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 04.10.2012 |
| A-ONLINE CAPITAL (A.O.C) LTD. | Präsident | 01.01.2002 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
THCG, Inc.
THCG, Inc. Finance/Rental/LeasingFinance Provides venture funding, venture development, and venture banking services | Finance |
A-Online Capital (A.O.C.) Ltd.
A-Online Capital (A.O.C.) Ltd. Packaged SoftwareTechnology Services Develops trading and investment portfolio analysis software solutions | Technology Services |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
Autovative Products, Inc.
Autovative Products, Inc. Wholesale DistributorsDistribution Services Produces and distributes automotive parts | Distribution Services |
Cazador Acquisition Corp. Ltd.
Cazador Acquisition Corp. Ltd. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rogerscasey, Inc.
Rogerscasey, Inc. Investment ManagersFinance Provides investment consulting services | Finance |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Stentomics, Inc. | |
Ucansi, Inc.
Ucansi, Inc. Packaged SoftwareTechnology Services Develops solutions for treating presbyopia | Technology Services |
Odysseus Ventures Ltd. | |
InnoVision Labs, Inc.
InnoVision Labs, Inc. Packaged SoftwareTechnology Services Operates as visual neuroscience software technology company | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen